skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8847

Development of a vaccine to prevent Japanese encephalitis: a brief review

Review

(3858) Views  (720) Full article downloads

Authors: Viroj Wiwanitkit

Published Date October 2009 Volume 2009:2 Pages 195 - 200
DOI: http://dx.doi.org/10.2147/IJGM.S6281

Viroj Wiwanitkit

Wiwanitkit House, Bangkhae, Bangkok, Thailand

Abstract: Japanese encephalitis (ICD 10: A83.0) is an important specific viral encephalitis caused by the Japanese encephalitis virus, a virus of the Flavivirus group. Millions of people, especially those in endemic areas of developing countries in Asia, are at high risk from this infection. Therefore proper management to deal with this virus is essential. There is no specific treatment for Japanese encephalitis virus. Supportive and symptomatic treatments are usually used, which emphasize the importance of prevention in this specific neurological disorder. Vector control or vaccination can be used to prevent the disease. Because the existing Japanese encephalitis vaccine poses some undesirable problems, a new vaccine is needed. The process of developing a new vaccine is briefly discussed.

Keywords: Japanese encephalitis, vaccine, concept, prevention, development






 

Other articles by Professor Viroj Wiwanitkit



Readers of this article also read:

A six-month double-blind, placebo-controlled, randomized clinical trial of duloxetine for the treatment of fibromyalgia
Radiolucency below the crown of mandibular horizontal incompletely impacted third molars and acute inflammation in men with diabetes
Role of aliskiren in cardio-renal protection and use in hypertensives with multiple risk factors
Exacerbation rate, health status and mortality in COPD – a review of potential interventions
The pathophysiology of bronchiectasis
Clinical effectiveness of the Respimat® inhaler device in managing chronic obstructive pulmonary disease: evidence when compared with other handheld inhaler devices
Green synthesis and characterization of gelatin-based and sugar-reduced silver nanoparticles
Erratum
Hepatotoxicity due to tocilizumab and anakinra in rheumatoid arthritis: two case reports
Lyme disease and pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections (PANDAS): an overview
  • Testimonials

    "... I was impressed at the rapidity of publication from submission to final acceptance." Dr Edwin Thrower, PhD, Yale University